Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 1, 2016
Pharmacy Choice - News - Over-the-Counter Drugs - July 1, 2016

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 18 of 18     Go To Page:

7/1/16 - Allergan Receives Positive Opinion Through European Decentralised Procedure For BELKYRA (Deoxycholic Acid) For Patients With Submental Fullness
Allergan plc, a leading global pharmaceutical company, today announced that it has received a Positive Opinion from the Swedish Medical Products Agency for BELKYRA . BELKYRA will be the first prescription medicine to be licensed in Europe for the treatment of moderate to severe convexity or fullness associated with submental fat in adults wh
7/1/16 - Helsinn Group Signs Agreement With Vifor Pharma for the Promotion and Distribution of Aloxi
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announces that the Company has signed an agreement, with Vifor Pharma for the promotion and distribution of Aloxi , an anti-nausea therapeutic medicine used to help prevent symptoms of chemotherapy-induced nausea and vomiting, in Spain. Under the terms of the n
7/1/16 - iHear Medical Launches the World's First Cloud-Based Hearing Solutions
The company begins taking orders today for its flagship invisible iHEARHD hearing aid, and the iHearTest?, which recently received landmark Federal Drug Administration approval as the first and only home hearing screener. The company also plans to launch the iHEARMAX?, a mini behind-the-ear hearing device, on August 15, 2016. iHear's product
6/30/16 - Federal Register Table of Contents
Table of Contents Office of the Federal Register Agency for Healthcare Research and Quality NOTICES Meetings: National Advisory Council for Healthcare Research and Quality, 42709 Aging Administration NOTICES Agency Information Collection Activities; Proposals, Submissions, and Approvals: State Annual Long-Term Care Ombudsman Report, 42712-42713...
6/30/16 - Moberg Pharma enters into a definitive agreement to acquire three U.S. OTC brands from Prestige Brands
Moberg Pharma AB has signed an agreement to acquire New Skin , Fiber Choice and PediaCare , three well-established Over-The-Counter brands in the U.S. from Prestige Brands, Inc. In the latest 12 months ending March 31, 2016, the Net sales of these brands was approximately $24.4 million. The purchase price is $40 million and Moberg Pharma exp
6/30/16 - Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the...
SUMMARY: The Food and Drug Administration is issuing this proposed rule to amend the 1994 tentative final monograph or proposed rule for over-the-counter antiseptic drug products. In the 1994 TFM, certain antiseptic active ingredients were proposed as being GRAS for antiseptic rub use by consumers based on safety data evaluated by FDA as part of it
6/30/16 - Sparo gets FDA clearance for asthma-related device [St. Louis Post-Dispatch]
June 30 A St. Louis firm has received clearance to sell a pocket-sized device that will help asthma patients know how well their lungs are functioning. The clearance from the U.S. Food and Drug Administration means that Sparo Labs can sell its product, called Wing, as an over-the-counter medical device. Brimer and co-founder Abby Cohen started Sp
6/29/16 - BioPharmX Announces Positive Topline Phase 2a Clinical Trial Results for BPX-01 in Patients with Acne-Causing Bacteria
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, today announced topline results from its Phase 2 a safety study of BPX-01, a unique topical gel formulation of minocycline. Results from the first human trial of BPX-01 showed the product reported no cutaneous toxicity, resulted in no adverse
6/29/16 - July/August Issue of AARP Bulletin includes an exclusive on Hillary Clinton's and Donald Trump's Social Security positions, "99 Great Ways to Save," and the dangers of nutritional supplements
WASHINGTON, June 29, 2016/ PRNewswire-USNewswire/ Among all the issues that Hillary Clinton and Donald Trump are hotly debating during the election season, few impact 50- plus Americans as much as Social Security. Trump& Clinton Where They Stand On Social Security: Earlier this year, AARP invited presidential candidates Hillary Clinton and Don
6/29/16 - Medical Devices; General and Plastic Surgery Devices; Classification of the Electrosurgical Device for Over-the-Counter Aesthetic Use
FOR FURTHER INFORMATION CONTACT: Long Chen, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. In accordance with section 513 of the Federal Food, Drug, and Cosmetic Act, devices that were not in commercial distribution before May 28, 1976, generally referred to as postamendments device
6/29/16 - Microbiology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
SUMMARY: The Food and Drug Administration announces a forthcoming public advisory committee meeting of the Microbiology Devices Panel of the Medical Devices Advisory Committee. FDA is establishing a docket for public comment on this document. ADDRESSES: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room, Silv
6/29/16 - Researchers Submit Patent Application, "System for Using Medication Samples to Measure Medication Acquisition and Improve Patient Outcomes", for...
Researchers Submit Patent Application, "System for Using Medication Samples to Measure Medication Acquisition and Improve Patient Outcomes", for Approval. By a News Reporter-Staff News Editor at Biotech Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Di Lascia, Christopher; Di Lascia, Francis; Kapu
6/29/16 - TherapeuticsMD Announces Filing Timeline for Yuvvexy (TX-004HR) New Drug Application
TherapeuticsMD, Inc., an innovative women s healthcare company, announced today that it expects that the New Drug Application for Yuvvexy, the conditionally approved trade name for the Company s TX-004HR drug candidate, will be submitted to the Food and Drug Administration on or before July 15, 2016. TherapeuticsMD completed the phase 3 Rejoi
6/28/16 - Endo Announces Issuance of Vasostrict Patent
DUBLIN, June 28, 2016/ PRNewswire/ Endo International plc today announced that one of its operating companies, Par Pharmaceutical, has been issued a new patent by the U.S. Patent and Trademark Office relating to Vasostrict 20 units/mL. This Orange Book listing requires any Abbreviated New Drug Application applicant seeking FDA approval for a g
6/28/16 - FDA Advisory Committee recommends approval of Jardiance (empagliflozin) for cardiovascular indication in 12-11 vote
RIDGEFIELD, Conn. and INDIANAPOLIS, June 28, 2016/ PRNewswire/ A U.S. Food and Drug Administration Advisory Committee today voted 12-11 that substantial evidence exists to establish that Jardiance reduces cardiovascular death in adults with type 2 diabetes and established CV disease. JARDIANCE, which is marketed by Boehringer Ingelheim and Eli
6/28/16 - Moberg Pharma announces launch in Japan and provides market update for Kerasal Nail and Emtrix
Moberg Pharma AB today announced that its partner, Menarini Asia-Pacific, recently initiated the launch of Emtrix in Japan and that the initial consumer response has been strong. The launch has been initiated in a part of Japan by Moberg Pharma's partner Menarini Asia-Pacific. Moberg Pharma's distribution agreement with the Menarini Group- a t
6/27/16 - Narcotics Control Bureau to sensitise pharma industry on illegal use of chemicals [Arab News (Saudi Arabia)]
Aiming to stop the illegal diversion of certain chemical formulations used to prepare drugs, such as heroin and' methamphetamine', the Narcotics Control Bureau has planned to sensitise the pharmaceutical industry to curb the practice. According to Zonal Director of Ahmedabad NCB Hari Om Gandhi, pharma and chemical companies can play a crucial role
6/25/16 - "Methods for Treating Dry Eye Disease by Administering an Il-6r Antagonist" in Patent Application Approval Process (USPTO 20160152717)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors CAO, Jingtai; HU, Ying; ROMANO, Carmelo; WIEGAND, Stanley J., filed on December 1, 2015, was made available online on June 9, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent appli
Articles(s): 1 - 18 of 18     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415